Drug Approvals
🇺🇸 FDA Page 15FDA news and analysis for pharmaceutical BD, investment, and market access · 12 articles on this page
Track global drug approvals & regulatory decisions. Gain critical intelligence on new therapies, market access, and competitive landscapes for pharma BD.
Showing 169–180 of 665 articles
FDA Expands ENDS Market Access: Implications for Pharma BD and Investors
FDA · 8 min
Dr. Sarah MitchellCitius Pharmaceuticals Stock Update: Cancer and Anti-Infective Pipeline Insights
FDA · cancer · 11 min
Dr. Sarah MitchellFDA to Issue Guidance on Animal-Derived Thyroid Products by August 2026, Signaling Regulatory Shift
FDA · Graves' Disease · 8 min
Dr. Sarah MitchellGlobal Regulatory Roundup: Key Updates for June 1, 2026
FDA · Dermatologicals · 7 min
Dr. Sarah MitchellBiotech M&A Trends: Navigating the 2026 Outlook for Strategic Growth
9 min
Dr. Sarah MitchellBig Pharma's Shift to Smaller Deals Boosts Biotech Sector
6 min
Dr. Sarah MitchellRallybio Taps Avenzo Therapeutics for Reverse Merger to Advance Oncology Pipeline
8 min
Dr. Sarah MitchellLegend Biotech Presents Promising CARVYKTI and LB2102 Data at ASCO
7 min
Dr. Sarah MitchellCDC Prioritizes Ebola Containment, Highlighting Critical Role of Clinical Trials
CDC · Ebola · 9 min
Dr. Sarah MitchellAsia Surges as Biopharma Innovation Hub, Driving Global Drug Approvals
5 min
Dr. Sarah MitchellDEA Reschedules Marijuana to Schedule III, Expediting Medical Access and Research
DEA · 7 min
Dr. Sarah MitchellFDA Expert Panel to Review Peptide Access, Impacting Compounded Drug Market
FDA · 5 min
Dr. Sarah MitchellExplore intelligence